Targeted disruption of protein kinase Cε reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma

Cancer Research

Volumn 66, Issue 19, 2006, Pages 9379-9384

  Pan, Quintin ^a,b   Bao, Li Wei ^a   Teknos, Theodoros N ^b   Merajver, Sofia D ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; NUCLEOTIDE BINDING PROTEIN; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C GAMMA; PROTEIN KINASE C ZETA; RHOA GTPASE; RHOC GTPASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOLECULAR CLONING; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TARGET CELL; WESTERN BLOTTING;

CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; ENZYME ACTIVATION; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN KINASE C-EPSILON; PROTEIN PROCESSING, POST-TRANSLATIONAL; RHO GTP-BINDING PROTEINS; RHOA GTP-BINDING PROTEIN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 33750379275     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-2646     Document Type: Article

References (24)

1. Genden EM, Ferlito A, Bradley PJ, Rinaldo A, Scully C. Neck disease and distant metastases. Oral Oncol 2003;39:207-12.
2. Dimery IW, Hong WK. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 1993;85:95-111.
3. Carter CA. Protein kinase C as a drug target: implications for drug or diet prevention and treatment of cancer. Curr Drug Targets 2000;1:163-83.
4. Cacace AM, Guadagno SN, Krauss RS, Fabbro D, Weinstein IB. The ε isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene 1993;8:2095-104.
5. Mischak H, Goodnight JA, Kolch W, et al. Overexpression of protein kinase C-δ and -ε in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem 1993;268:6090-6.
6. Jansen AP, Verwiebe EG, Dreckschmidt NE, et al. Protein kinase C-ε transgenic mice: a unique model for metastatic squamous cell carcinoma. Cancer Res 2001;61:808-12.
7. Dong G, Lee TL, Yeh NT, et al. Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering, and metastasis in response to hepatocyte growth factor. Oncogene 2004;23:6199-208.
8. Worden B, Yang XP, Lee TL, et al. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma. Cancer Res 2005;65:7071-80.
9. Kermorgant S, Zicha D, Parker PJ. PKC controls HGF-dependent c-Met traffic, signalling, and cell migration. EMBO J 2004;23:3721-34.
10. Pan Q, Bao LW, Kleer CG, et al. Protein kinase Cε is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anti-cancer therapy. Cancer Res 2005;65:8366-71.
11. Martinez-Gimeno C, Diaz-Meco MT, Dominguez I, Moscat J. Alterations in levels of different protein kinase C isotypes and their influence on behavior of squamous cell carcinoma of the oral cavity: εPKC, a novel prognostic factor for relapse and survival. Head Neck 1995;17:516-25.
12. Ridley AJ, Schwartz MA, Burridge K, et al. Cell migration: integrating signals from front to back. Science 2003;302:1704-9.
13. Nobes CD, Hall A. Rho, rac, cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995;81:53-62.
14. Sahai E, Marshall CJ. Rho-GTPases and cancer. Nat Rev Cancer 2002;2:133-42.
15. Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am J Pathol 2002;160:579-84.
16. Fritz G, Just I, Kaina B. Rho GTPases are overexpressed in human tumors. Int J Cancer 1999;81:682-7.
17. Fritz G, Brachetti C, Bahlmann F, Schmidt M, Kaina B. Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br J Cancer 2002;87:635-44.
18. Abraham MT, Kuriakose MA, Sacks PG, et al. Motility-related proteins as markers for head and neck squamous cell carcinoma. Laryngoscope 2001;111:1285-9.
19. Kleer CG, Teknos TN, Islam M, et al. RhoC-GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinoma of the head and neck. Clin Cancer Res 2006;12:4485-90.
20. Rolli-Derkinderen M, Sauzeau V, Boyer L, et al. Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells. Circ Res 2005;96:1152-60.
21. Mira JP, Benard V, Groffen J, Sanders LC, Knaus UG. Endogenous, hyperactive Rac3 controls the proliferation of breast cancer cells by a p21-aclivated kinase-dependent pathway. Proc Natl Acad Sci U S A 2000;97:185-9.
22. Mehta D, Rahman A, Malik AB. Protein kinase C-α signals rho-guanine nucleotide dissociation inhibitor phosphorylation and rho activation and regulates the endothelial cell barrier function. J Biol Chem 2001;25:22614-20.
23. Holinstat M, Mehta D, Kozasa T, Minshall RD, Malik AB. Protein kinase Cα-induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangement. J Biol Chem 2003;278:28793-8.
24. Brouns MR, Matheson SF, Hu KQ, et al. The adhesion signaling molecule p190 RhoGAP is required for morphogenetic processes in neural development. Development 2000;127:4891-903.